Sandeep M. Nayak, MD

Randomized trials of psychedelics underutilize blind assessment, active drug controls, and testing psychological support against minimal-support conditions—elements that would improve quality or provide important information.

The authors note two suicidality-related events that occurred within the studies included in their recent meta-analysis.